Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ConsortiEX is a private U.S. healthcare technology company focused on pharmacy compliance, drug traceability, and IV workflow management for hospitals, health systems, and 503B outsourcing facilities. Its core offerings include DSCSA Compliance as a Service and the Assure-Trak compounding management system, which support ordering, production, distribution, and tracking of pharmaceuticals from supply chain pedigree through patient administration. The company positions itself as a software-and-services provider rather than a drug developer, with emphasis on regulatory compliance under DSCSA, DQSA, USP <795>, USP <797>, and USP <800>. ConsortiEX appears to serve a large installed base of hospital and pharmacy customers across the United States and markets its solutions around patient safety, operational efficiency, and audit readiness. For a biotech analyst, this is best understood as a commercial-stage healthcare IT and pharmacy operations company, not a therapeutics biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ConsortiEX.